Position in AMGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$377,725,045
+$34,388,971 QoQ
Shares Held
1,073,540
+2.3% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.33656873521247.ToString("F0")%
Shared 0.7504145164595637.ToString("F0")%
None 1.9130167483279619.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $51,364,425,965 across 16 Drug Manufacturers - General names. AMGN ranks #5 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,328,908 | $47,210,789,709 | |
| 2 | JNJ |
Johnson & Johnson
|
5,752,985 | $1,406,259,649 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,530,441 | $905,836,743 | |
| 4 | ABBV |
AbbVie Inc.
|
4,114,966 | $894,963,949 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,073,540 | $377,725,045 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,379,304 | $204,954,785 | |
| 7 | PFE |
Pfizer Inc
|
6,971,622 | $195,763,142 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
486,271 | $67,771,586 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $377,725,045 | 1,073,540 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $343,336,074 | 1,048,963 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $314,728,625 | 1,115,268 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $282,025,827 | 1,010,085 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $319,074,551 | 1,024,152 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $265,321,872 | 1,017,963 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $335,008,176 | 1,039,720 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $333,717,216 | 1,068,066 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $307,432,085 | 1,081,289 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $317,334,670 | 1,101,780 | Shares | Defined | 2024-03-22 | |
| 2023-09-30 | $293,140,023 | 1,090,713 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $232,814,830 | 1,048,621 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $268,847,032 | 1,112,087 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $298,896,661 | 1,138,047 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $260,583,132 | 1,156,092 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $285,746,844 | 1,174,463 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $285,958,192 | 1,182,525 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $272,401,319 | 1,210,834 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $313,234,933 | 1,473,007 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $380,502,765 | 1,561,037 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $391,950,637 | 1,575,301 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $380,346,534 | 1,654,256 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $434,373,922 | 1,709,057 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $402,471,735 | 1,706,401 | Shares | Defined | 2020-08-28 | |
| 2020-03-31 | $351,063,278 | 1,731,679 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||